146 related articles for article (PubMed ID: 31515528)
21. Binding of Resveratrol to Vascular Endothelial Growth Factor Suppresses Angiogenesis by Inhibiting the Receptor Signaling.
Hu WH; Duan R; Xia YT; Xiong QP; Wang HY; Chan GK; Liu SY; Dong TT; Qin QW; Tsim KW
J Agric Food Chem; 2019 Jan; 67(4):1127-1137. PubMed ID: 30525561
[TBL] [Abstract][Full Text] [Related]
22. Piceatannol, a Natural Analog of Resveratrol, Exerts Anti-angiogenic Efficiencies by Blockage of Vascular Endothelial Growth Factor Binding to Its Receptor.
Hu WH; Dai DK; Zheng BZ; Duan R; Dong TT; Qin QW; Tsim KW
Molecules; 2020 Aug; 25(17):. PubMed ID: 32824997
[TBL] [Abstract][Full Text] [Related]
23. Timosaponin AIII, a steroidal saponin, exhibits anti-tumor effect on taxol-resistant cells in vitro and in vivo.
Song XY; Han FY; Chen JJ; Wang W; Zhang Y; Yao GD; Song SJ
Steroids; 2019 Jun; 146():57-64. PubMed ID: 30951756
[TBL] [Abstract][Full Text] [Related]
24. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.
Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875
[TBL] [Abstract][Full Text] [Related]
25. Marine compound catunaregin inhibits angiogenesis through the modulation of phosphorylation of akt and eNOS in vivo and in vitro.
Liu JX; Luo MQ; Xia M; Wu Q; Long SM; Hu Y; Gao GC; Yao XL; He M; Su H; Luo XM; Yao SZ
Mar Drugs; 2014 May; 12(5):2790-801. PubMed ID: 24824025
[TBL] [Abstract][Full Text] [Related]
26. OSU-A9 inhibits angiogenesis in human umbilical vein endothelial cells via disrupting Akt-NF-κB and MAPK signaling pathways.
Omar HA; Arafa el-SA; Salama SA; Arab HH; Wu CH; Weng JR
Toxicol Appl Pharmacol; 2013 Nov; 272(3):616-24. PubMed ID: 23921148
[TBL] [Abstract][Full Text] [Related]
27. Kaempferol inhibits angiogenic ability by targeting VEGF receptor-2 and downregulating the PI3K/AKT, MEK and ERK pathways in VEGF-stimulated human umbilical vein endothelial cells.
Chin HK; Horng CT; Liu YS; Lu CC; Su CY; Chen PS; Chiu HY; Tsai FJ; Shieh PC; Yang JS
Oncol Rep; 2018 May; 39(5):2351-2357. PubMed ID: 29565448
[TBL] [Abstract][Full Text] [Related]
28. Timosaponin AIII: A novel potential anti-tumor compound from Anemarrhena asphodeloides.
Han FY; Song XY; Chen JJ; Yao GD; Song SJ
Steroids; 2018 Dec; 140():125-130. PubMed ID: 30296545
[TBL] [Abstract][Full Text] [Related]
29. Mechanistic Study of the In Vitro and In Vivo Inhibitory Effects of Protocatechuic Acid and Syringic Acid on VEGF-Induced Angiogenesis.
Hu J; Lin S; Huang JJ; Cheung PCK
J Agric Food Chem; 2018 Jul; 66(26):6742-6751. PubMed ID: 29886729
[TBL] [Abstract][Full Text] [Related]
30. Notoginsenoside Ft1 promotes angiogenesis via HIF-1α mediated VEGF secretion and the regulation of PI3K/AKT and Raf/MEK/ERK signaling pathways.
Shen K; Ji L; Gong C; Ma Y; Yang L; Fan Y; Hou M; Wang Z
Biochem Pharmacol; 2012 Sep; 84(6):784-92. PubMed ID: 22771629
[TBL] [Abstract][Full Text] [Related]
31. Anti-angiogenic effect of auranofin on HUVECs in vitro and zebrafish in vivo.
He MF; Gao XP; Li SC; He ZH; Chen N; Wang YB; She JX
Eur J Pharmacol; 2014 Oct; 740():240-7. PubMed ID: 25064343
[TBL] [Abstract][Full Text] [Related]
32. Anti-angiogenic activity and mechanism of kaurane diterpenoids from Wedelia chinensis.
Huang W; Liang Y; Wang J; Li G; Wang G; Li Y; Chung HY
Phytomedicine; 2016 Mar; 23(3):283-92. PubMed ID: 26969382
[TBL] [Abstract][Full Text] [Related]
33. Pro-angiogenic effects of Ilexsaponin A1 on human umbilical vein endothelial cells in vitro and zebrafish in vivo.
Li J; Zhang J; Zou L; Lee SM; Yang C; Seto SW; Leung GP
Phytomedicine; 2017 Dec; 36():229-237. PubMed ID: 29157819
[TBL] [Abstract][Full Text] [Related]
34. Xinkeshu tablets promote angiogenesis in zebrafish embryos and human umbilical vein endothelial cells through multiple signaling pathways.
Liu Q; Zhang H; An Y; Zhang Y; He Q; Liu K; Xia Q; Zhou H
J Ethnopharmacol; 2023 Oct; 314():116636. PubMed ID: 37182673
[TBL] [Abstract][Full Text] [Related]
35. PHMH, a diarylheptanoid from Alpinia officinarum attenuates VEGF-induced angiogenesis via inhibition of the VEGFR-2 signaling pathway.
Hu L; Huang W; Ding Y; Liu M; Wang M; Wang Y; Zhang W; Li Y; Ye W; Li M; Liu Z
Food Funct; 2019 May; 10(5):2605-2617. PubMed ID: 31020299
[TBL] [Abstract][Full Text] [Related]
36. The Antiangiogenesis Effect of Pirfenidone in Wound Healing In Vitro.
Liu X; Yang Y; Guo X; Liu L; Wu K; Yu M
J Ocul Pharmacol Ther; 2017 Nov; 33(9):693-703. PubMed ID: 28933986
[TBL] [Abstract][Full Text] [Related]
37. Murrangatin suppresses angiogenesis induced by tumor cell-derived media and inhibits AKT activation in zebrafish and endothelial cells.
Long W; Wang M; Luo X; Huang G; Chen J
Drug Des Devel Ther; 2018; 12():3107-3115. PubMed ID: 30288018
[TBL] [Abstract][Full Text] [Related]
38. Novel PI3K/AKT targeting anti-angiogenic activities of 4-vinylphenol, a new therapeutic potential of a well-known styrene metabolite.
Yue GG; Lee JK; Kwok HF; Cheng L; Wong EC; Jiang L; Yu H; Leung HW; Wong YL; Leung PC; Fung KP; Lau CB
Sci Rep; 2015 Jun; 5():11149. PubMed ID: 26053458
[TBL] [Abstract][Full Text] [Related]
39.
Cho HD; Kim JH; Park JK; Hong SM; Kim DH; Seo KI
Pharm Biol; 2019 Dec; 57(1):684-693. PubMed ID: 31608754
[No Abstract] [Full Text] [Related]
40. Dioscin inhibits colon tumor growth and tumor angiogenesis through regulating VEGFR2 and AKT/MAPK signaling pathways.
Tong Q; Qing Y; Wu Y; Hu X; Jiang L; Wu X
Toxicol Appl Pharmacol; 2014 Dec; 281(2):166-73. PubMed ID: 25111127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
